Merck
MRK
#48
Rank
A$434.47 B
Marketcap
A$173.94
Share price
3.79%
Change (1 day)
19.50%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): A$11.22

According to Merck's latest financial reports the company's current EPS (TTM) is A$10.26. an increase over its 2024 EPS that were of A$9.50.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025A$10.237.71%
2024A$9.504308.46%
2023A$0.22-97.32%
2022A$8.0510.92%
2021A$7.2684.68%
2020A$3.93-27.2%
2019A$5.4063.44%
2018A$3.30151.11%
2017A$1.32-54.58%
2016A$2.9030.21%
2015A$2.22-61.99%
2014A$5.85180.51%
2013A$2.09-31.82%
2012A$3.066.62%
2011A$2.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.65 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.34 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.91-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.27-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.34 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.13 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.90-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.17-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.29-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.74-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel